You just read:

Sanofi's Formulation Patents on Multibillion-Dollar Lantus® are Invalidated by U.S. Patent and Trademark Office via IPR, Announces Mylan

News provided by

Mylan N.V.

Dec 13, 2018, 07:30 ET